EUA Begins Rolling Review of Modernas mRNA Vaccine Candidate Against COVID-19
Moderna, Inc.,a biotechnology company pioneering messenger RNA therapeutics and vaccines to create a new generation...
Mallinckrodt Initiates Retrospective Study of the Use of Inhaled Nitric Oxide in COVID-19 Patients
Mallinckrodt plc, a global biopharmaceutical company, announced initiation of a retrospective chart review study, titled...
Cancer Treatment Can Be Cloned For COVID-19
As per the recent international study by the scientists from Italy & Australia, Beta-blockers have...
Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis...
Pfizer Inc. and BioNTech SE announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated...
Pfizer Announces Positive Phase 3 Study Results for XELJANZ in Ankylosing Spondylitis
Pfizer Inc. announced positive results from a Phase 3 investigational study evaluating the safety and...
Phesi analysis shows difference of up to three months in current COVID-19 vaccine trial...
Analysis from virtual clinical development specialist Phesi shows the enrollment and effectiveness of two current...
Tiziana begins study of nasally administered Foralumab either alone or in combo with dexamethasone...
Tiziana Life Sciences, a biotechnology company, announced initiation of a collaborative clinical study investigating nasally...
Mayo Clinic Collaborates with Vocalis Health for Clinical Development of Vocal Biomarkers
Mayo Clinic and Vocalis Health, Inc., a company pioneering AI-based vocal biomarkers for use in...
Bimekizumab Phase 3 Data Shows Superior Skin Clearance Over Humira in Moderate-to-Severe Psoriasis Patients
UCB, a global biopharmaceutical company, announced the detailed results of the head-to-head Phase 3 BE...
Novavax Provides Phase 3 COVID-19 Vaccine Clinical Development Update
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced updates...
